[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL2482658T3 - Sposoby i kompozycje do leczenia objawu Raynauda - Google Patents

Sposoby i kompozycje do leczenia objawu Raynauda

Info

Publication number
PL2482658T3
PL2482658T3 PL10821290T PL10821290T PL2482658T3 PL 2482658 T3 PL2482658 T3 PL 2482658T3 PL 10821290 T PL10821290 T PL 10821290T PL 10821290 T PL10821290 T PL 10821290T PL 2482658 T3 PL2482658 T3 PL 2482658T3
Authority
PL
Poland
Prior art keywords
raynaud
phenomenon
compositions
treatment
methods
Prior art date
Application number
PL10821290T
Other languages
English (en)
Inventor
Robert Cook
Original Assignee
Microdose Therapeutx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc
Publication of PL2482658T3 publication Critical patent/PL2482658T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10821290T 2009-09-30 2010-09-30 Sposoby i kompozycje do leczenia objawu Raynauda PL2482658T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24732309P 2009-09-30 2009-09-30
PCT/US2010/050983 WO2011041595A1 (en) 2009-09-30 2010-09-30 Methods and compositions for treatment of raynaud's phenomenon
EP10821290.3A EP2482658B1 (en) 2009-09-30 2010-09-30 Methods and compositions for treatment of raynaud's phenomenon

Publications (1)

Publication Number Publication Date
PL2482658T3 true PL2482658T3 (pl) 2015-10-30

Family

ID=43780649

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10821290T PL2482658T3 (pl) 2009-09-30 2010-09-30 Sposoby i kompozycje do leczenia objawu Raynauda

Country Status (8)

Country Link
US (1) US20110076334A1 (pl)
EP (1) EP2482658B1 (pl)
KR (2) KR101644286B1 (pl)
CN (1) CN102665413A (pl)
CA (1) CA2775061A1 (pl)
ES (1) ES2543470T3 (pl)
PL (1) PL2482658T3 (pl)
WO (1) WO2011041595A1 (pl)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
DE3326089A1 (de) * 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
SE9303657D0 (sv) * 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
US6026809A (en) * 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
US6897305B2 (en) * 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
US7919119B2 (en) 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US8820316B2 (en) * 2000-02-11 2014-09-02 Respironics Respiratory Drug Delivery (Uk) Ltd Drug delivery apparatus
MX347325B (es) * 2007-06-20 2017-04-12 Milestone Pharmaceuticals Inc Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.
US7834041B2 (en) * 2007-09-07 2010-11-16 Theravance, Inc. Dual-acting antihypertensive agents
CN101224207A (zh) * 2007-10-12 2008-07-23 中国科学院上海有机化学研究所 具有诱导自吞噬治疗错误折叠蛋白聚集所致疾病的药物及其筛选方法
CN102186351A (zh) * 2008-08-01 2011-09-14 医药公司 药物组合物和用于稳定药物组合物的方法
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.

Also Published As

Publication number Publication date
EP2482658A4 (en) 2013-12-25
CA2775061A1 (en) 2011-04-07
KR20120100945A (ko) 2012-09-12
EP2482658B1 (en) 2015-07-01
KR20150110828A (ko) 2015-10-02
ES2543470T3 (es) 2015-08-19
EP2482658A1 (en) 2012-08-08
US20110076334A1 (en) 2011-03-31
KR101644286B1 (ko) 2016-08-10
CN102665413A (zh) 2012-09-12
WO2011041595A1 (en) 2011-04-07

Similar Documents

Publication Publication Date Title
EP2364161A4 (en) COMPOSITIONS CONTAINING SATIOGENES AND METHODS OF USE
GB2469245B (en) Antimicrobial compositions and methods of use thereof
PL2448581T3 (pl) Kompozycje terapeutyczne i odnośne sposoby ich stosowania
IL208858A0 (en) Lipid-containing compositions and methods of use thereof
GB201108374D0 (en) Compositions and methods for the treatment of altered synuclein function
ZA201008713B (en) Antimicrobial compositions and methods of use
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
EP2326171A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2249789A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF XEROSOMY
EP2271750A4 (en) URICASE COMPOSITIONS AND METHODS OF USE
IL214349A0 (en) Compositions and methods for the treatment of cancer
HK1211472A1 (en) Compositions and methods of treatment comprising ceftaroline
HK1167101A1 (en) Compositions and methods for treatment of multiple sclerosis
ZA201102207B (en) Cinnamandehyde-allicin compositions and their method of use
EP2437738A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
PL2498613T3 (pl) Kompozycje biobójcze i sposoby ich stosowania
PL2375912T3 (pl) Kompozycje i sposoby leczenia uczucia dyskomfortu gardła
EP2411031A4 (en) Methods and compositions for the treatment of cancer
HK1166953A1 (en) Compositions and methods of use
EP2470016A4 (en) SYNERGISTIC COMPOSITION AND METHOD OF USE
PL2482658T3 (pl) Sposoby i kompozycje do leczenia objawu Raynauda
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
GB0804122D0 (en) Treatment of raynaud's phenomenon